Clinical trials referenced in this document:
Documents that mention this clinical trial
Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressure
Funding for this research was provided by:
FP7 International Cooperation (305507)
Received: 3 June 2021
Accepted: 29 July 2021
First Online: 9 August 2021
: The study was approved by all relevant ethics committees and regulatory bodies. All participants provided written informed consent prior to study-specific procedures.
: There is no data of individual persons included in the manuscript.
: The authors have no relevant conflicts of interest to disclose with regards to the content of this manuscript.